The impact of HLA on long-term outcome after thymectomy for myasthenia gravis (Q47750832)

5 February 2018

title

The impact of HLA on long-term outcome after thymectomy for myasthenia gravis (English)

1 reference

5 February 2018

0 references

0 references

Machens A

1 reference

5 February 2018

Löliger C

1 reference

5 February 2018

Pichlmeier U

1 reference

5 February 2018

Emskötter T

1 reference

5 February 2018

Busch C

1 reference

5 February 2018

Izbicki JR

1 reference

5 February 2018

publication date

1 August 1998

1 reference

5 February 2018

Journal of Neuroimmunology

published in

1 reference

5 February 2018

volume

1 reference

5 February 2018

issue

1-2

1 reference

5 February 2018

page(s)

177-181

1 reference

5 February 2018

The role of the thymus in myasthenia gravis: immunohistological and immunological studies in 115 cases.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2898%2900120-9

7 January 2021

Long-term outcome and quality of life after thymectomy for myasthenia gravis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2898%2900120-9

7 January 2021

Muscle acetylcholine receptor loss in murine experimental autoimmune myasthenia gravis: correlated with cellular, humoral and clinical responses

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2898%2900120-9

7 January 2021

An approach to the localization of the susceptibility genes for generalized myasthenia gravis by mapping recombinant ancestral haplotypes

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2898%2900120-9

7 January 2021

HLA-DR, DQ and DP typing using PCR amplification and immobilized probes

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2898%2900120-9

7 January 2021

HLA type is not indicative for the effect of thymectomy in myasthenia gravis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2898%2900120-9

7 January 2021

A one-step monoclonal antibody typing procedure that simplifies HLA class I and class II typing

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2898%2900120-9

7 January 2021

Nomenclature for factors of the HLA system, update March 1995. WHO Nomenclature Committee for factors of the HLA system

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2898%2900120-9

7 January 2021

Myasthenia gravis patients with thymus hyperplasia and myasthenia gravis patients with thymoma display different HLA associations

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2898%2900120-9

7 January 2021

Identification by genomic typing of non-DR3 HLA class II genes associated with myasthenia gravis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2898%2900120-9

7 January 2021

Thymic myogenesis, T-lymphocytes and the pathogenesis of myasthenia gravis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2898%2900120-9

7 January 2021

Depletion of CD8+ T cells suppresses the development of experimental autoimmune myasthenia gravis in Lewis rats

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2898%2900120-9

7 January 2021

Both CD4+ and CD8+ T cells are essential to induce experimental autoimmune myasthenia gravis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2898%2900120-9

7 January 2021

10.1016/S0165-5728(98)00120-9

Identifiers

DOI

1 reference

5 February 2018

1 reference

5 February 2018